Skip to Main Content

Paper Details

Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
Mol Ther Oncolytics
13
2020
Author NameAffiliation
Hiroki SatoLaboratory Animal Research Center, The Institute of Medical Science, The University of Tokyo
Misako YonedaLaboratory Animal Research Center, The Institute of Medical Science, The University of Tokyo
Chieko KaiLaboratory Animal Research Center, The Institute of Medical Science, The University of Tokyo
  • 1 - 3

Datasets

Release 1.2